BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55. [PMID: 10768432 [PMID: 10768432 DOI: 10.1016/s0140-6736(00)90011-4] [Cited by in Crossref: 1317] [Cited by in F6Publishing: 1] [Article Influence: 59.9] [Reference Citation Analysis]
Number Citing Articles
1 de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 [PMID: 31885424 DOI: 10.3748/wjg.v25.i47.6835] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
2 Mazeron J. Cancers ORL localement évolués : chimioradiothérapie ou accélération de la radiothérapie ? Bulletin du Cancer 2012;99:901-2. [DOI: 10.1684/bdc.2012.1633] [Reference Citation Analysis]
3 Murono S, Komori T, Endo K, Kondo S, Wakisaka N, Yoshizaki T. Intra-arterial chemotherapy targeting metastatic cervical lymph nodes in head and neck cancer. Acta Otolaryngol 2021;141:1063-9. [PMID: 34825623 DOI: 10.1080/00016489.2021.2003858] [Reference Citation Analysis]
4 Usman M, Tanveer F, Ilyas A, Zarina S. Varlitinib Mediates Its Activity Through Down Regulating MAPK/EGFR Pathway in Oral Cancer. CP 2020;17:51-8. [DOI: 10.2174/1570164616666190516114749] [Reference Citation Analysis]
5 Huguet F, Durand B, Atallah S, Prébet C, Richard S, Baujat B. Combination of radiation therapy-immunotherapy for head and neck cancers: Promises kept? Cancer Radiother 2021;25:811-5. [PMID: 34711485 DOI: 10.1016/j.canrad.2021.08.018] [Reference Citation Analysis]
6 Roman E, Raez LE, Santos ES. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. Expert Rev Anticancer Ther 2006;6:1205-15. [PMID: 17020455 DOI: 10.1586/14737140.6.9.1205] [Reference Citation Analysis]
7 Goepfert H. Advanced laryngeal cancer: current best management: “The paradigm is shifting, but not much.”: . Current Opinion in Otolaryngology & Head and Neck Surgery 2002;10:112-7. [DOI: 10.1097/00020840-200204000-00009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Pointreau Y, Schick U, Huguet F. Place et intérêt de la chimiothérapie d’induction des cancers des voies aérodigestives supérieures. Cancer/Radiothérapie 2017;21:505-9. [DOI: 10.1016/j.canrad.2017.07.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Brizel D. Management of human papillomavirus-induced oropharynx cancer. Am Soc Clin Oncol Educ Book 2012;:368-71. [PMID: 24451765 DOI: 10.14694/EdBook_AM.2012.32.57] [Reference Citation Analysis]
10 Lewis CM, Hutcheson KA, Kupferman ME. Comparative effectiveness in head and neck malignancies. Cancer Treat Res 2015;164:89-99. [PMID: 25677020 DOI: 10.1007/978-3-319-12553-4_6] [Reference Citation Analysis]
11 Grau JJ. Induction chemotherapy prior to surgery did not improve survival, but may reduce mandibulectomy over surgery alone in locally advanced squamous cell cancer of the oral cavity. Cancer Treatment Reviews 2003;29:341-4. [DOI: 10.1016/s0305-7372(03)00136-1] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
12 Rivera F, Eugenia Vega-Villegas M, López C, Francisca López-Brea M, Rubio A, Del Valle A, García-Reija F, García-Montesinos B, Rodríguez-Iglesias J, Hinojo C, Márquez R, Angel Alonso-Bermejo M, Salcedo M, Blanco Y, Vega N, López-Tarruella S, Sanz-Ortiz J. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer. Acta Oncol 2008;47:1584-9. [PMID: 18607841 DOI: 10.1080/02841860802089793] [Reference Citation Analysis]
13 Martinez J, Otley CC, Okuno SH, Foote RL, Kasperbauer JL. Chemotherapy in the Management of Advanced Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: Theoretical and Practical Considerations. Dermatologic Surgery 2004;30:679-86. [DOI: 10.1097/00042728-200404020-00018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Yu J, Tsay C, Sasaki C, Son YH, Decker RH, Mehra S, Burtness B. Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Oral Oncol 2021;122:105585. [PMID: 34688055 DOI: 10.1016/j.oraloncology.2021.105585] [Reference Citation Analysis]
15 Giralt J, Benavente S. Controversies surrounding the use of neoadjuvant chemotherapy in locally advanced head and neck cancer. Expert Rev Anticancer Ther 2008;8:1359-63. [PMID: 18759687 DOI: 10.1586/14737140.8.9.1359] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Lal P, Tiwari A, Verma A, Maria Das KJ, Baijal SS, Bajpai R, Kumar P, Srivastava A, Kumar S. Role of videofluorography in assessing functional abnormalities in patients of head and neck cancer treated with chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 2009;5:264-9. [DOI: 10.1111/j.1743-7563.2009.01241.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Colevas AD. Organ preservation-induction chemotherapy. Cancer Treat Res 2003;114:213-34. [PMID: 12619543 DOI: 10.1007/0-306-48060-3_8] [Reference Citation Analysis]
18 Mellas N, Elmesbahi O, Masbah O, Errihani H. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future]. Bull Cancer 2010;97:211-23. [PMID: 20051349 DOI: 10.1684/bdc.2009.0980] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Lere-Chevaleyre A, Bernadach M, Lambert C, Cassagne L, Puechmaille M, Mom T, Gilain L, Lapeyre M, Boirie Y, Biau J, Saroul N. Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass. Head Neck 2021. [PMID: 34918416 DOI: 10.1002/hed.26954] [Reference Citation Analysis]
20 Blanchard P, Bourhis J, Lacas B, Le Teuff G, Michiels S, Pignon JP. [Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives]. Cancer Radiother 2015;19:198-204; quiz 228-9, 233. [PMID: 25858708 DOI: 10.1016/j.canrad.2014.12.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Fung AS, Afzal AR, Banerjee R, Debenham B, Hao D. A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma. Head Neck 2021;43:153-63. [PMID: 32949087 DOI: 10.1002/hed.26469] [Reference Citation Analysis]
22 Qiu SS, Cambeiro M, Hontanilla B. Comparison of quality of life in head and neck stage IV squamous cell cancer patients treated with surgery and reconstruction versus radical radiotherapy. Ann Plast Surg 2014;73:205-9. [PMID: 23403545 DOI: 10.1097/SAP.0b013e318270449e] [Reference Citation Analysis]
23 Parmar A, Macluskey M, Mc Goldrick N, Conway DI, Glenny AM, Clarkson JE, Worthington HV, Chan KK. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev 2021;12:CD006386. [PMID: 34929047 DOI: 10.1002/14651858.CD006386.pub4] [Reference Citation Analysis]